Abstract
Acute lymphoblastic leukemia (ALL), the most common cancer in childhood, is characterized by clonal proliferation of transformed lymphoblasts that comprise the majority of marrow and/or blood specimens. Although the leukemic cells typically express antigens associated with lymphoid maturation or activation (ie CD19, CD38, etc), it has been suggested that ALL blasts may evolve from a more primitive precursor. Increased understanding of the phenotypic and molecular heterogeneity of cells in ALL may provide clues to leukemogenesis and/ or impact prognostication or treatment. We utilized a phenotype/genotype approach to measure the prevalence and frequency of cytogenetically aberrant cells in a phenotypically defined primitive compartment (CD34+33−19−38−; CD34+Lin−). Bone marrow cells were flow cytometrically sorted into CD34−Lin+, CD34+Lin+ and CD34+Lin− subpopulations. Fluorescence in situ hybridization (FISH) was used to quantify the frequency of cells with aneusomies in the sorted populations. Approximately 26% (5/19) of ALL cases at diagnosis contain cytogenetically aberrant CD34+Lin− cells. The frequency of cytogenetically aberrant cells in the CD34+Lin− compartment is independent of FAB, WBC and blast counts. These data indicate that cytogenetically aberrant cells may reside in a phenotypically defined primitive subpopulation and suggest that ALL blasts in some patients may evolve from a precursor compartment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quijano, C., Moore, D., Arthur, D. et al. Cytogenetically aberrant cells are present in the CD34+CD33−38−19− marrow compartment in children with acute lymphoblastic leukemia. Leukemia 11, 1508–1515 (1997). https://doi.org/10.1038/sj.leu.2400754
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400754
Keywords
This article is cited by
-
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia
Current Treatment Options in Oncology (2022)
-
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
Nature Medicine (2005)
-
Leukaemia stem cells and the evolution of cancer-stem-cell research
Nature Reviews Cancer (2005)